Figure 3From: C-reactive protein in patients with advanced metastatic renal cell carcinoma: Usefulness in identifying patients most likely to benefit from initial nephrectomy ROC curve of CRP values for overall rate of death before the median survival period. Cohort of patients with AM-RCC who underwent nephrectomy (n = 95; median survival = 25.7 months) was analyzed. Back to article page